GST : 27AEUPJ3828B1ZE

Call us now

08045475302

Send Inquiry

Request To Call Back

Trastuzumab 440 Mg Injection

Name: Trastuzumab 440 Mg Injection
Brand: DATTATRAYA MEDICAL & GENERAL STORES
Price: 15000 INR
Availability: InStock

Price 15000 INR/ Box

Get a Price/Quote

MOQ : 1 Box

Trastuzumab 440 Mg Injection Specification

Packaging Type
Vial

Dosage Form
Lyophilized powder for injection

Life Span
24 months

Origin of Medicine
India

Brand Name
CANMAB

Indication
Metastatic breast, gastric cancer

Pacakaging (Quantity Per Box)
1 vial per box

Salt Composition
Trastuzumab

Drug Type
Biological

Ingredients
Trastuzumab

Physical Form
Injection

Function
Anticancer

Recommended For
HER2-positive breast cancer, gastric cancer

Dosage
As directed by the physician

Dosage Guidelines
Follow physicians instructions

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store at 2C-8C, do not freeze

Route
Intravenous

Reconstitution Required
Yes

Appearance
White to off-white powder

Prescription
Prescription only

Dilution Required
Yes

Marketed By
Biocon

Strength
440 mg

Diluent Included
Yes

HER2 Status
Positive required

Trastuzumab 440 Mg Injection Trade Information

Minimum Order Quantity
1 Box

Supply Ability
1000 Boxes Per Month

Delivery Time
7 Days

About Trastuzumab 440 Mg Injection

Pick yours from our rarefied collection-the Trastuzumab 440 Mg Injection (CANMAB), a champion in first-class cancer care, now available on ephemeral clearance. Specially designed for HER2-positive metastatic breast and gastric cancer, this biological marvel by Biocon is delivered as a white to off-white lyophilized powder requiring dilution and reconstitution. With its potent antineoplastic action, CANMAB brings first-class therapeutic efficacy to adults under physician guidance. Secure this exceptional vial while stock lasts and join the league of those choosing first-class treatment.

Outstanding Benefits & Advanced Features

CANMAB (Trastuzumab 440 Mg Injection) distinguishes itself with its rarefied composition, offering targeted action for HER2-positive cancers. Ready-to-reconstitute powder, supplied with diluent, ensures precise dosing. Backed by Biocon's champion manufacturing, each vial promises a 24-month shelf life with optimal storage at 2-8C. Tamper-proof packaging and stringent quality assurance make CANMAB a true first-class option for healthcare institutions and professionals focusing on advanced cancer therapies.

Domestic & Export Market Coverage

Trastuzumab 440 Mg Injection enjoys strong rates across India's main domestic markets and is frequently supplied from major FOB ports. Each single vial per box is delivered with meticulous packaging to ensure product integrity throughout transit. As a leading exporter, supplier, and trader from India, we keep expenditure competitive for both local institutions and the export market, making CANMAB an attractive therapeutic investment worldwide.

FAQ's of Trastuzumab 440 Mg Injection:

Q: How should Trastuzumab 440 Mg Injection be stored?

A: Trastuzumab 440 Mg Injection must be stored between 2C and 8C. Ensure that it is not frozen and keep it in its original packaging until use to maintain its potency and stability.

Q: What is the process for preparing this injection?

A: The injection is supplied as a lyophilized powder and requires both reconstitution and dilution. Carefully follow the provided instructions using the included diluent, and administer intravenously as directed by a healthcare professional.

Q: When is Trastuzumab 440 Mg Injection recommended?

A: This injection is indicated for adults with HER2-positive metastatic breast or gastric cancer. The dosage and treatment schedule are determined by the prescribing physician based on patient needs and cancer progression.

Q: Where is CANMAB (Trastuzumab) primarily marketed and exported from?

A: CANMAB is mainly marketed across India and exported globally through major Indian ports. The product consistently meets high demand among hospitals, clinics, and cancer treatment centers in both domestic and international markets.

Q: What are the primary benefits of choosing CANMAB over alternatives?

A: CANMAB offers a champion combination of targeted efficacy, first-class manufacturing quality, long shelf life, and thoughtfully designed packaging. Backed by Biocon's reputation, it provides reliable results for HER2-positive cancer therapy.

Tell us about your requirement